Dr. Lau Chak Sing Wallace - Rheumatology
Specialist in Rheumatology
Highlights
- MCHK RegisteredVerified
- 1 LocationsWong Chuk Hang
- Specialist in RheumatologyBachelor of Medicine and Bachelor of Surgery, University of Dundee · Member of the Royal Colleges of Physicians of the United Kingdom · MD (Dund) · Medical degree 1985
- InsuranceBeing compiled｜See details
About
Dr. Lau Chak Sing Wallace practises Rheumatology in Wong Chuk Hang, Hong Kong.
Education
Specialist in Rheumatology
- Bachelor of Medicine and Bachelor of Surgery, University of DundeeBachelor of Medicine and Bachelor of Surgery, University of Dundee1985
- Member of the Royal Colleges of Physicians of the United KingdomMember of the Royal Colleges of Physicians of the United Kingdom1988
- MD (Dund)
- Fellow of the Hong Kong Academy of Medicine (Medicine)Fellow of the Hong Kong Academy of Medicine (Medicine)
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Locations
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Lau Chak Sing Wallace? Claim page and update insurance →
FAQ
Is Dr. Lau Chak Sing Wallace any good?
Dr. Lau Chak Sing Wallace practises Rheumatology in Wong Chuk Hang, Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Lau Chak Sing Wallace do?
Dr. Lau Chak Sing Wallace practises in Rheumatology.
Where does Dr. Lau Chak Sing Wallace practise?
Dr. Lau Chak Sing Wallace practises at Gleneagles Hong Kong Hospital.
Are you Dr. Lau Chak Sing Wallace? Claim this page to update and manage.
ClaimResearch and publications
152 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- A prospective multicenter randomized controlled trial pre-emptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission.Kidney international · 2026
- Association of Reduction in Continuity of Care During COVID-19 Pandemic With Cardiovascular Diseases, Kidney Failure and All-Cause Mortality for People With Diabetes: A Cohort Study in Hong Kong.Diabetes, obesity & metabolism · 2026
- Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort study.Arthritis research & therapy · 2026
- Serum type I interferon promotes AIM2 inflammasome dysregulation in lupus patients through STAT1 and STAT2.Rheumatology (Oxford, England) · 2026
- Two-year prognosis of mRNA vaccine-related myocarditis compared with historical conventional myocarditis: a population-based cohort study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2026
- Predictors of damage accrual by organ domain in systemic lupus erythematosus.Rheumatology (Oxford, England) · 2026
- Indirect effect of the COVID-19 pandemic on mortality, complications, and healthcare utilization among people with Chronic Kidney Disease in Hong Kong: an interrupted time series analysis.Journal of nephrology · 2026
- Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.The Journal of rheumatology · 2026
- Infection risk in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs: Prediction models and use of machine learning.Joint bone spine · 2026
- Systematic evaluation of long-read and short-read sequencing in neurological disorders diagnosis: a direct comparison study of 310 patients.NPJ genomic medicine · 2026
- Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.Drug safety · 2026
- Modeling Hereditary Angioedema With Personalized Expanded Potential Stem Cell-Derived Hepatocytes: A CRISPR-Validated Platform for Mutation-Specific Mechanisms and Therapeutic Innovation.Allergy · 2026
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
Elsewhere on the web
Hospital pages
These links are matched automatically by the doctor's name and are not confirmed by the doctor. Names repeat in Hong Kong — open a link to check.
For reference only. Not medical advice. Read full disclaimer